Latest Insider Transactions at Illumina, Inc. (ILMN)
This section provides a real-time view of insider transactions for Illumina, Inc. (ILMN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ILLUMINA, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ILLUMINA, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 26
2021
|
Caroline Dorsa Director |
BUY
Grant, award, or other acquisition
|
Direct |
881
+8.49%
|
-
|
|
May 26
2021
|
Robert S Epstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
881
+12.06%
|
-
|
|
May 26
2021
|
Gary S Guthart Director |
BUY
Grant, award, or other acquisition
|
Direct |
881
+10.89%
|
-
|
|
May 26
2021
|
Susan E Siegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
881
+13.6%
|
-
|
|
May 25
2021
|
Caroline Dorsa Director |
SELL
Payment of exercise price or tax liability
|
Direct |
385
-4.28%
|
$152,845
$397.09 P/Share
|
|
May 25
2021
|
Robert S Epstein Director |
SELL
Payment of exercise price or tax liability
|
Direct |
385
-6.49%
|
$152,845
$397.09 P/Share
|
|
May 25
2021
|
Gary S Guthart Director |
SELL
Payment of exercise price or tax liability
|
Direct |
385
-5.73%
|
$152,845
$397.09 P/Share
|
|
May 25
2021
|
Susan E Siegel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
385
-7.55%
|
$152,845
$397.09 P/Share
|
|
May 24
2021
|
Charles Dadswell SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
314
-4.82%
|
$126,542
$403.04 P/Share
|
|
May 20
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
500
-1.14%
|
$200,000
$400.0 P/Share
|
|
May 18
2021
|
Jay T Flatley Director |
SELL
Open market or private sale
|
Direct |
4,000
-2.62%
|
$1,516,000
$379.53 P/Share
|
|
May 05
2021
|
Jose Torres VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
793
+49.81%
|
-
|
|
May 05
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
300
-0.68%
|
$114,300
$381.88 P/Share
|
|
May 04
2021
|
Jay T Flatley Director |
SELL
Open market or private sale
|
Direct |
4,000
-2.55%
|
$1,536,000
$384.15 P/Share
|
|
Apr 22
2021
|
Charles Dadswell SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
314
-4.6%
|
$126,228
$402.02 P/Share
|
|
Apr 20
2021
|
Jay T Flatley Director |
SELL
Open market or private sale
|
Direct |
4,000
-2.49%
|
$1,604,000
$401.83 P/Share
|
|
Apr 06
2021
|
Aimee L Hoyt SVP, Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,000
-8.55%
|
$424,000
$424.22 P/Share
|
|
Apr 06
2021
|
Jay T Flatley Director |
SELL
Open market or private sale
|
Direct |
4,000
-2.43%
|
$1,692,000
$423.44 P/Share
|
|
Apr 06
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
500
-1.12%
|
$211,500
$423.44 P/Share
|
|
Apr 05
2021
|
Aimee L Hoyt SVP, Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,000
-14.06%
|
$386,000
$386.03 P/Share
|
|
Apr 05
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
300
-0.67%
|
$115,800
$386.03 P/Share
|
|
Apr 05
2021
|
Phillip G. Febbo SVP Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
131
-2.34%
|
$50,304
$384.54 P/Share
|
|
Mar 22
2021
|
Charles Dadswell SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
314
-4.39%
|
$130,624
$416.24 P/Share
|
|
Mar 16
2021
|
Jay T Flatley Director |
SELL
Open market or private sale
|
Direct |
4,000
-2.37%
|
$1,684,000
$421.06 P/Share
|
|
Mar 05
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
800
-1.75%
|
$321,600
$402.24 P/Share
|
|
Mar 02
2021
|
Jay T Flatley Director |
SELL
Open market or private sale
|
Direct |
4,000
-2.31%
|
$1,776,000
$444.61 P/Share
|
|
Feb 18
2021
|
Karen K Mcginnis VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
666
-30.22%
|
$323,676
$486.75 P/Share
|
|
Feb 17
2021
|
Charles Dadswell SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,635
-18.62%
|
$807,690
$494.24 P/Share
|
|
Feb 17
2021
|
Charles Dadswell SVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,503
+28.52%
|
-
|
|
Feb 17
2021
|
Charles Dadswell SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
386
+6.82%
|
-
|
|
Feb 17
2021
|
Francis A De Souza President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,194
-15.35%
|
$6,517,836
$494.24 P/Share
|
|
Feb 17
2021
|
Francis A De Souza President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,521
+22.2%
|
-
|
|
Feb 17
2021
|
Francis A De Souza President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,698
+4.21%
|
-
|
|
Feb 17
2021
|
Phillip G. Febbo SVP Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,454
-20.64%
|
$718,276
$494.24 P/Share
|
|
Feb 17
2021
|
Phillip G. Febbo SVP Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,173
+31.05%
|
-
|
|
Feb 17
2021
|
Phillip G. Febbo SVP Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
350
+8.29%
|
-
|
|
Feb 17
2021
|
Aimee L Hoyt SVP, Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,762
-19.86%
|
$870,428
$494.24 P/Share
|
|
Feb 17
2021
|
Aimee L Hoyt SVP, Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,625
+34.26%
|
-
|
|
Feb 17
2021
|
Aimee L Hoyt SVP, Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
509
+10.7%
|
-
|
|
Feb 17
2021
|
Karen K Mcginnis VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
372
-14.44%
|
$183,768
$494.24 P/Share
|
|
Feb 17
2021
|
Karen K Mcginnis VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
935
+26.63%
|
-
|
|
Feb 17
2021
|
Karen K Mcginnis VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
103
+5.91%
|
-
|
|
Feb 17
2021
|
Robert P Ragusa SVP, Global Quality & Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
3,178
-24.84%
|
$1,569,932
$494.24 P/Share
|
|
Feb 17
2021
|
Robert P Ragusa SVP, Global Quality & Ops |
BUY
Exercise of conversion of derivative security
|
Direct |
6,306
+33.01%
|
-
|
|
Feb 17
2021
|
Robert P Ragusa SVP, Global Quality & Ops |
BUY
Grant, award, or other acquisition
|
Direct |
694
+9.66%
|
-
|
|
Feb 17
2021
|
Sam Samad SVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,170
-23.2%
|
$1,071,980
$494.24 P/Share
|
|
Feb 17
2021
|
Sam Samad SVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,379
+31.88%
|
-
|
|
Feb 17
2021
|
Sam Samad SVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
482
+8.83%
|
-
|
|
Feb 17
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,178
-6.5%
|
$1,569,932
$494.24 P/Share
|
|
Feb 17
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,306
+11.42%
|
-
|